Mass Spectrometry-Based Comprehensive Analysis of Pancreatic Cyst Fluids

Table 3

Peptidases (P) and peptidase inhibitors (I) in the degradome fraction for which a different number of peptides were identified between combined CA, MCN, and SCN versus PC and IPMN groups.

UniProt ACC	Name	P/I	IPMN	PC	MCN	SCN	CA
P15085	Carboxypeptidase A1	P	53	64	6	7	19
P48052	Carboxypeptidase A2	P	11	14	0	1	3
P15086	Carboxypeptidase B	P	45	48	3	4	7
P08217	Chymotrypsin-like elastase family member 2A	P	7	7	1	1	2
P08218	Chymotrypsin-like elastase family member 2B	P	6	6	0	1	0
P09093	Chymotrypsin-like elastase family member 3A	P	9	8	3	1	3
P08861	Chymotrypsin-like elastase family member 3B	P	5	5	1	1	2
P07477	Trypsin-1	P	10	12	0	1	4
P07478	Trypsin-2	P	13	13	0	0	1
P00738	Haptoglobin	I/P	31	36	11	10	19
P04196	Histidine-rich glycoprotein	I	5	7	1	1	2
P01042	Kininogen-1	I	3	3	10	6	9
Q99895	Chymotrypsin-C	P	4	3	0	0	1

CA, carcinoma; SCN, serous cystic neoplasm; MCN, mucinous cystic neoplasm; IPMN, intraductal papillary mucinous neoplasm; PC, pseudocyst.